EMBCV (EMBCV) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 5 8 sessions, March 22, 2022 to March 31, 2022
- Largest daily move
- -10.6% close of March 23, 2022
Company Description
EMBCV (Nasdaq: EMBCV) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.9B.
EMBCV has declined 25.0% over the past week. The last closing price was $33.33.
This page collects what Stock Titan holds for EMBCV, including price data and latest news.
Stock Performance
EMBCV (EMBCV) closed at $33.33 on March 31, 2022. Over the past week, the price has lost 25.0%.
EMBCV Metrics & Rankings
Price returns through March 31, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
EMBCV has 10 recent news articles. Key topics include conferences, earnings, partnership, dividends. View all EMBCV news →
SEC Filings
EMBCV Company Profile & Sector Positioning
EMBCV (EMBCV) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing EMBCV often look at related companies in the same sector, including Plus Prods Inc (PLPRF), H Lundbeck (HLUKF), BioCryst Pharmaceuticals Inc (BCRX), Phibro Animal Health Corporation (PAHC), and Avadel Pharmaceuticals plc (AVDL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMBCV's relative position within its industry.